617P Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101)H. Kikuchi, S. Oizumi, Kunihiro Tsuji et al.|Annals of Oncology|2024Cited by 1